Peter Kadas Overview
- Company
- Marex Group
- Primary Position
-
Non-Executive Di...
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
Peter Kadas General Information
Biography
Mr. Peter Kadas served as Non-Executive Director at Marex Spectron. Mr. Peter Kadas serves as Board Member at Treos Bio. Kadas also served as Senior Advisor at BXR Group. He also served as vice-chairman of the board of directors of OKD from 2006 to 2007. He has also served as director of BXR Real Estate Investments B.V. and RPG Property B.V. since 2006 and 2008 respectively. Mr Kadas is a Senior Advisor of BXR Partners LLP, an affiliate of BXR Group. From 2001 until 2010 he was a director of Bakala Crossroads Partners Ltd, also a BXR Group affiliate. Between 1997 and 2001 he was a managing director of Croesus Central Europe and from 1996 to 1997 he worked as a managing director for MC Securities in London. In 1995 he co-founded Renaissance Capital, Russia's first private investment bank. In 1990 he was a Director of Credit Suisse First Boston in Budapest. Mr Kadas also served on numerous corporate boards in the region, including CSFB, the management committee of Renaissance Capital, and vice-chairman of the board of directors of České radiokomunikace. Mr Kadas graduated in 1986 from Trinity College, University of Toronto with a Bachelor of Arts degree in Economics and Politics. In 1990 he obtained a Master of Business Administration degree from Dartmouth College.
Contact Information
Address
- 1st Floor
- 40-44 Newman Street
- London W1T 1QD
- England, United Kingdom
Peter Kadas Board Seats (1)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Treos Bio | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | London, United Kingdom |
Peter Kadas Lead Partner on Deals (1)
Peter Kadas has been the lead partner on 1 deal. Their latest deal was with Treos Bio, a drug discovery company. The deal was made for on 30-Sep-2019.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Treos Bio | 30-Sep-2019 | Early Stage VC (Series A) | Completed | Drug Discovery | London, United Kingdom |
Peter Kadas Network (55)
Board Members (47)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Konstantin Schweinitz | Marex Group | Self | London, United Kingdom | |
Ian Lowitt | Marex Group | Marex Group | London, United Kingdom | |
Treos Bio | Outsized Ventures | London, United Kingdom | ||
Marex Group | JRJ Group | London, United Kingdom | ||
Marex Group | Self | London, United Kingdom |
Portfolio Executives (8)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Menghis Bairu MD | Treos Bio | Executive Chairman | 30-Sep-2019 | London, United Kingdom |
Enikő Tőke Ph.D | Treos Bio | Chief Scientific Officer & Board Member | 30-Sep-2019 | London, United Kingdom |
Treos Bio | Chief Financial Officer & Board Member | 30-Sep-2019 | London, United Kingdom | |
Treos Bio | Chief Medical Officer | 30-Sep-2019 | London, United Kingdom | |
Treos Bio | Co-Founder & Board Member | 30-Sep-2019 | London, United Kingdom |
Peter Kadas FAQs
-
Who is Peter Kadas?
Mr. Peter Kadas served as Non-Executive Director at Marex Spectron.
-
How much does Peter Kadas typically invest?
Peter Kadas's median deal size is
. -
What is Peter Kadas’s main position?
Peter Kadas’s primary position is Non-Executive Director.
-
What are the contact details for Peter Kadas?
Peter Kadas’s email address is pk
and his phone number is +44 020 . -
How many active board seats does Peter Kadas hold?
Peter Kadas holds a board seat in Treos Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »